Capstan Medical is hiring! We are a dynamic growing company within Structural Heart medical devices. Just one example of our jobs for a Sr. R&D Test engineer is here: https://lnkd.in/gkH-ruaS All Capstan jobs are within our website: https://lnkd.in/gKCZUh-E If you are looking for a fulfilling career within a growing dynamic company we encourage you to apply!
About us
At Capstan Medical, we’re driven by an unwavering commitment to transforming the treatment of structural heart disease. By merging surgical robotics with catheter-based technology and next generation implants, we’ve pioneered a patient-optimized approach to repair and replace heart valves.
- Website
-
http://www.capstanmedical.com
External link for Capstan Medical
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Santa Cruz, CA
- Type
- Privately Held
Locations
-
Primary
Get directions
2801 Mission St
#239
Santa Cruz, CA 95060, US
Employees at Capstan Medical
Updates
-
We’re thrilled to share a recent feature from Eclipse Ventures highlighting Capstan Medical. Earlier this year, we reached a groundbreaking milestone with the world’s first percutaneous, robotic-assisted mitral valve replacement — a procedure that could transform the way heart valve disease is treated worldwide. Our mission is to make minimally invasive heart valve procedures more widely available, bringing new hope to patients everywhere. 👏 A big congratulations to our Capstan team for continuing to push the boundaries of cardiac care. 👉 Read more about this important breakthrough: https://bit.ly/3IswmCG #MedicalInnovation #CardiacCare #HealthcareTransformation #Robotics #HeartHealth #CapstanMedical #EclipseInvestors #mitralvalve
Capstan Medical is redefining the future of heart valve surgery. Earlier this year, the company made history with the world’s first percutaneous, robotic-assisted mitral valve replacement, a procedure that could transform treatment for millions living with heart valve disease. Unlike traditional open-heart surgery — which involves breaking the sternum, stopping the heart, and months of recovery — Capstan’s platform uses tiny incisions and robotics to precisely navigate a replacement valve into place while the heart is still beating. The potential impact is staggering: Only 2% of eligible patients currently receive life-saving treatment due to high surgical risks, access challenges, and limited minimally invasive options. Capstan’s system removes these barriers, making treatment safer, simpler, and more accessible. Founded by leaders from Intuitive, Auris Health, Inc., Abbott, and Boston Scientific, Capstan unites decades of expertise in robotics, minimally invasive surgery, and cardiac care. Supported by Eclipse since its early days, Capstan is moving quickly — with first-in-human trials already underway and plans to expand globally. Capstan’s innovation represents more than a new product — it’s a vision of a world where heart surgery is no longer a life-halting event, but a routine, precise, and empowering experience for patients and clinicians alike. Read more: https://bit.ly/3IswmCG Maggie Nixon, Dan Wallace, Justin Butler, Spencer Noe, Evelyn Haynes, Travis Schuh
-
-
-
-
-
+3
-
-
We are excited to have Meg Carr join us as Head of Regulatory for Occam Labs supporting all portfolio companies including Capstan Medical and Versa Vascular. Meg brings a wealth of experience navigating the complex regulatory pathways associated with catheter-based cardiac interventions and implantables. Her expertise will be incredibly valuable in our next stage of agency engagement and clinical development. Welcome Meg! P.S. - Meg is hiring...If you are a passionate and curious regulatory professional that wants to work on cutting-edge technology, please reach out!
-
-
Thank you Fierce Biotech! It's a privilege to be amongst such incredible companies bringing innovation to the patients that need it most.
Fierce Medtech's Fierce 15 is live! In medtech, innovation almost always means iteration, but that doesn’t preclude novel breakthroughs. These Fierce 15 companies identify unmet needs that were beyond the reach of yesterday’s technologies, building on existing standards to drive new modalities, safer approaches and more accessible science. Congratulations to the Fierce 15! Averto Medical, Inc, Capstan Medical, Distalmotion, Elixir Medical Corporation, FastWave Medical, FIRE1 , Kardium Inc., Mendaera, Inc., Model Medicines, Precision Neuroscience, Proscia, Route 92 Medical, Scale Biosciences, Sequel Med Tech, Virtual Incision https://lnkd.in/g_KfFnai
-
Capstan is excited to announce that Greg Dachs joined us this week as Head of R&D. Greg brings a wealth of experience in robotics, hardware and technology scaling that will be incredibly valuable in our next phase of development. Welcome Greg!
-
-
At Capstan, we continue our journey to bring minimally invasive options to heart valve patients that need it most. https://lnkd.in/gNCBA5EK
-
Capstan Medical reposted this
Creating products that matter by delighting users and impacting patient outcomes. Focused on developing the RIGHT PRODUCT before spending resources on building the product right.
Thank you Franca Melfi and EACTS - European Association for Cardio-Thoracic Surgery. Such a fantastic conference with engaging discussions, debates, and interdisciplinary perspectives! Happy to share about my journey at both Intuitive and Capstan Medical. Thank you for the opportunity!
Today Amy Kerdok, the Head of Product at Capstan Medical and our Honoured Guest, delivered an inspiring talk - Innovation in Surgery: Looking back to Look forward at #EACTS2024 💥 "We must stay curious! Once you solve the problem, you've probably opened the door to six more!"
-